Showing results (781-790 of 899) with videos related to

Sort By:
Pageof 90
Journal of Neuromuscular Diseases|April 7, 2026
Navigating new motor function trajectories: Consensus recommendations for assessment in the era of newborn screening and early treatment in SMAKristin J Krosschell, Sally Dunaway Young, Elizabeth Maczek, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2016
Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene CohortsJason D Keene, Sean Jacobson, Katerina Kechris, et al.
American Journal of Respiratory and Critical Care Medicine|August 27, 2016
Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICSCarlos H Martinez, Alejandro A Diaz, Catherine Meldrum, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 22, 2020
Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the SPIROMICS CohortChristopher B Cooper, Robert Paine, Jeffrey L Curtis, et al.
Journal of Occupational and Environmental Medicine|March 28, 2023
Association of Occupational Exposures and Chronic Obstructive Pulmonary Disease MorbidityJennifer S Rous, Peter S J Lees, Kirsten Koehler, et al.
Respiratory Research|November 21, 2018
Heterogeneous burden of lung disease in smokers with borderline airflow obstructionCheryl S Pirozzi, Tian Gu, Pedro M Quibrera, et al.
Plos One|April 13, 2018
Lower serum IgA is associated with COPD exacerbation risk in SPIROMICSNirupama Putcha, Gabriel G Paul, Antoine Azar, et al.
Annals of the American Thoracic Society|November 1, 2017
The Long-Term Oxygen Treatment Trial for Chronic Obstructive Pulmonary Disease: Rationale, Design, and Lessons LearnedRoger D Yusen, Gerard J Criner, Alice L Sternberg, et al.
JAMA Oncology|February 3, 2018
Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical TrialMartin J B Taphoorn, Linda Dirven, Andrew A Kanner, et al.
Cytotherapy|April 22, 2023
Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitnessElaine Lau, George Kwong, Tristan W Fowler, et al.
Pageof 90